Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Holders of 5% or more of VERV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Verve Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Pentwater Capital Management LP | 13G | 7.50%6.72M shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 7.00%6.18M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Verve Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20254:08 PM ET | Pentwater Capital Management LPand 1 other | 13G | 7.50%6.72M shares | New | Jun 30, 2025 | SEC |
| Aug 14, 20254:06 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2025 | SEC |
| Jul 28, 20255:21 PM ET | GV 2017, L.P.and 12 others | 13G/A | 0.00%0 shares | –Below 5% | Jul 25, 2025 | SEC |
| Apr 29, 20254:01 PM ET | Millennium Management LLCand 2 others | 13G | 4.90%4.33M shares | +0.30 ppfrom 4.60%Below 5% | Apr 22, 2025 | SEC |
| Apr 17, 20255:40 PM ET | BlackRock, Inc. | 13G/A | 7.00%6.18M shares | – | Mar 31, 2025 | SEC |
| Feb 5, 20257:53 AM ET | State Street Corp | 13G | 3.80%3.24M shares | NewBelow 5% | Dec 31, 2024 | SEC |
| Jan 31, 20254:00 PM ET | Millennium Management LLCand 3 others | 13G/A | 4.60%3.92M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 10, 20259:24 PM ET | ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 0.00%0 shares | –Below 5% | Sep 30, 2024 | SEC |
| Jan 16, 202411:45 AM ET | Singer James R | 13G/A | 3.70%3.00M shares | –Below 5% | Dec 31, 2023 | SEC |
| Dec 28, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jun 28, 2021 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 13GOld format | – | New | – | SEC |
| Jun 23, 2021 | Casdin Capital, LLC | 13GOld format | – | New | – | SEC |
| Jun 23, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Verve Therapeutics, Inc. shares.
No Form 144 notices for Verve Therapeutics, Inc. are on file.